{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T23:07:38Z","timestamp":1776726458794,"version":"3.51.2"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journalofclinicalvirology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.jcv.2015.12.003","type":"journal-article","created":{"date-parts":[[2015,12,18]],"date-time":"2015-12-18T01:42:57Z","timestamp":1450402977000},"page":"10-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Risk factors for cytomegalovirus DNAemia following haploidentical stem cell transplantation and its association with host hepatitis B virus serostatus"],"prefix":"10.1016","volume":"75","author":[{"given":"Yao","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan-Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Zhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Hua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2015.12.003_bib0005","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1182\/blood-2013-05-499830","article-title":"CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT","volume":"122","author":"Schmidt-Hieber","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jcv.2015.12.003_bib0010","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1182\/blood.V67.4.1162.1162","article-title":"Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease","volume":"67","author":"Miller","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.jcv.2015.12.003_bib0015","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/01.TP.0000109778.39235.F4","article-title":"Reduced risk for extensive chronic graft-versus-host disease in patients receiving transplants with human leukocyte antigen-identical sibling donors given polymerase chain reaction-based preemptive therapy against cytomegalovirus","volume":"77","author":"Larsson","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jcv.2015.12.003_bib0020","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/338624","article-title":"High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection","volume":"185","author":"Nichols","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2015.12.003_bib0025","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/jmv.23735","article-title":"An investigation on the relationship between the occurrence of CMV DNAemia and the development of invasive aspergillosis in the allogeneic stem cell transplantation setting","volume":"86","author":"Gim\u00e9nez","year":"2014","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jcv.2015.12.003_bib0030","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/sj.bmt.1704232","article-title":"Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patientsundergoing allogeneic hematopoietic stem cell transplantation","volume":"32","author":"Yanada","year":"2003","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.jcv.2015.12.003_bib0035","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1083-8791(03)00287-8","article-title":"Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies","volume":"9","author":"Boeckh","year":"2003","journal-title":"Biol. Blood Marrow Transpl."},{"issue":"3","key":"10.1016\/j.jcv.2015.12.003_bib0040","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1128\/JCM.42.3.1142-1148.2004","article-title":"Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR","volume":"42","author":"Boeckh","year":"2004","journal-title":"J. Clin. Microbiol."},{"issue":"2","key":"10.1016\/j.jcv.2015.12.003_bib0045","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1182\/blood-2002-03-0993","article-title":"Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity","volume":"101","author":"Boeckh","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jcv.2015.12.003_bib0050","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/sj.bmt.1702226","article-title":"Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection","volume":"25","author":"Einsele","year":"2000","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.jcv.2015.12.003_bib0055","doi-asserted-by":"crossref","first-page":"8039","DOI":"10.1073\/pnas.140123497","article-title":"Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy","volume":"97","author":"Emery","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jcv.2015.12.003_bib0060","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1182\/blood.V99.4.1159","article-title":"Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation","volume":"99","author":"Reusser","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jcv.2015.12.003_bib0065","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2007","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.jcv.2015.12.003_bib0070","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood-2003-10-3616","article-title":"The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy","volume":"113","author":"Boeckh","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jcv.2015.12.003_bib0075","doi-asserted-by":"crossref","first-page":"6465","DOI":"10.1182\/blood-2009-02-203307","article-title":"Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients","author":"Zhou","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jcv.2015.12.003_bib0080","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1399-3062.2010.00504.x","article-title":"Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy","volume":"12","author":"George","year":"2010","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.jcv.2015.12.003_bib0085","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.hoc.2010.11.011","article-title":"Cytomegalovirus in hematopoietic stem cell transplant recipients","volume":"25","author":"Ljungman","year":"2011","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"10.1016\/j.jcv.2015.12.003_bib0090","first-page":"1290","article-title":"High incidence of cytomegalovirus reactivation inadult recipients of an unrelated cord blood transplant","volume":"90","author":"Takami","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.jcv.2015.12.003_bib0095","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1182\/blood-2006-04-020313","article-title":"Umbilical cord blood transplantation and cytomegalovirus: posttransplantation infection and donor screening","volume":"108","author":"Albano","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jcv.2015.12.003_bib0100","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bbmt.2009.09.019","article-title":"Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation","volume":"16","author":"Beck","year":"2010","journal-title":"Biol. Blood Marrow Transpl."},{"issue":"2","key":"10.1016\/j.jcv.2015.12.003_bib0105","first-page":"77","article-title":"Application of real time polymerase chain reaction to the diagnosis and treatment of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation","volume":"30","author":"Chen","year":"2009","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.jcv.2015.12.003_bib0110","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/cncr.27761","article-title":"Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center","volume":"119","author":"Wang","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.jcv.2015.12.003_bib0115","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/sj.bmt.1705445","article-title":"Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies","volume":"38","author":"Huang","year":"2006","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.jcv.2015.12.003_bib0120","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-6143.2005.01207.x","article-title":"American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation","volume":"6","author":"Humar","year":"2006","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.jcv.2015.12.003_bib0125","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1086\/339329","article-title":"Definition of cytomegalovirus infection and disease in transplant recipients","volume":"34","author":"Ljungman","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcv.2015.12.003_bib0130","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1182\/blood.V99.8.3050","article-title":"Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation inrecipients of allogeneic bone marrow transplants","volume":"99","author":"Ljungman","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jcv.2015.12.003_bib0135","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.bbmt.2009.03.002","article-title":"Incidence, risk factors, and outcomeof cytomegalovirus infection and disease in patients receiving prophylaxis with oral valganciclovir or intravenous ganciclovir after umbilical cord blood transplantation","volume":"15","author":"Montesinos","year":"2009","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.jcv.2015.12.003_bib0140","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.bbmt.2012.05.015","article-title":"Efficacy of a viral load-based, risk-adapted, preemptive treatment strategy for prevention of cytomegalovirus disease after hematopoietic cell transplantation","volume":"18","author":"Green","year":"2012","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.jcv.2015.12.003_bib0145","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1128\/JVI.72.4.2630-2637.1998","article-title":"Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic mice","volume":"72","author":"Cavanaugh","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.jcv.2015.12.003_bib0150","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0168-8278(87)80544-5","article-title":"What is the effect of a cytomegalovirus infection when superimposed on HBsAg-positive chronic hepatitis?","volume":"4","author":"Vandelli","year":"1987","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jcv.2015.12.003_bib0155","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/030006059302100306","article-title":"Liver pathology in cytomegalovirus infection associated with hepatitis B virus","volume":"21","author":"Marinelli","year":"1993","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.jcv.2015.12.003_bib0160","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/ajh.22214","article-title":"The potential role of pre-transplant HBcIgGseroposivity as Transplant Network","volume":"87","author":"Marchesi","year":"2012","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.jcv.2015.12.003_bib0165","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00277-011-1351-8","article-title":"Cytomegalovirus infection and disease after allogeneichematopoietic stem cell transplantation: experience in a center with a high seroprevalence of both CMV and hepatitis B virus","volume":"91","author":"Liu","year":"2012","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.jcv.2015.12.003_bib0170","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jcv.2009.05.009","article-title":"Prevalence of human cytomegalovirus co-infection in patients with chronic viral hepatitis B and C: a comparison of clinical and histological aspects","volume":"45","author":"Bayram","year":"2009","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2015.12.003_bib0175","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1086\/314510","article-title":"Human herpesvirus 6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection","volume":"178","author":"DesJardin","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2015.12.003_bib0180","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1097\/00007890-200006270-00016","article-title":"Clinical relevance of human herpesvirus-6 infection in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and impact on outcome","volume":"69","author":"Rogers","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.jcv.2015.12.003_bib0185","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1086\/315391","article-title":"Human herpesvirus-6 is associated with cytomegalovirus reactivation in liver transplant recipients","volume":"181","author":"Humar","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2015.12.003_bib0190","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/(SICI)1096-9071(199711)53:3<295::AID-JMV20>3.0.CO;2-F","article-title":"Human herpesvirus-6 andhuman herpervirus-7 infections in bone marrow transplant recipients","volume":"53","author":"Chan","year":"1997","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jcv.2015.12.003_bib0195","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.bbmt.2009.12.003","article-title":"An assessment of the effect of human herpesvirus-6 replication on active cytomegalovirus infection after allogeneic stem cell transplantation","volume":"16","author":"Tormo","year":"2010","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.jcv.2015.12.003_bib0200","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.bbmt.2012.05.012","article-title":"HHV-6 reactivation and associated sequelae after hematopoietic cell transplantation","volume":"18","author":"Zerr","year":"2012","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.jcv.2015.12.003_bib0205","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/00007890-199602150-00014","article-title":"Increased infections in liver transplant recipients with recurrent hepatitis C virus hepatitis","volume":"61","author":"Singh","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.jcv.2015.12.003_bib0210","first-page":"116S","article-title":"Immunological mechanism in chronic hepatitis B virus infection","volume":"2","author":"Thomas","year":"1982","journal-title":"Hepatology"},{"key":"10.1016\/j.jcv.2015.12.003_bib0215","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1146\/annurev.immunol.21.120601.141110","article-title":"T cell anergy","volume":"21","author":"Schwartz","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jcv.2015.12.003_bib0220","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1128\/JVI.79.5.3016-3027.2005","article-title":"Immune tolerance split between hepatitis B virus precore and core proteins","volume":"79","author":"Chen","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.jcv.2015.12.003_bib0225","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1053\/j.gastro.2012.08.046","article-title":"Altered functions of plasmacytoid dendritic cells and reduced cytolytic activity of natural killer cells in patients with chronic HBV infection","volume":"143","author":"Martinet","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcv.2015.12.003_bib0230","doi-asserted-by":"crossref","first-page":"e49135","DOI":"10.1371\/journal.pone.0049135","article-title":"Natural killer cells are characterized by the concomitantly increased interferon-\u03b3 and cytotoxicity in acute resolved hepatitis B patients","volume":"7","author":"Zhao","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jcv.2015.12.003_bib0235","doi-asserted-by":"crossref","first-page":"e1002594","DOI":"10.1371\/journal.ppat.1002594","article-title":"TGF-\u03b21 down-regulation of NKG2D\/DAP10 and 2B4\/SAP expression on human NK cells contributes to HBV persistence","volume":"8","author":"Sun","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jcv.2015.12.003_bib0240","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.iy.13.040195.000333","article-title":"Hepatitis B virus immunopathogenesis","volume":"13","author":"Chisari","year":"1995","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jcv.2015.12.003_bib0245","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1172\/JCI119308","article-title":"Cytotoxic T cells and viral hepatitis","volume":"99","author":"Chisari","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jcv.2015.12.003_bib0250","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0016-5085(99)70289-1","article-title":"Direct ex viva analysis of hepatitis B virus specific CD8+ T cells associated with control of infection","volume":"117","author":"Maini","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcv.2015.12.003_bib0255","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1182\/blood-2003-12-4344","article-title":"Differential outcomes of human cytomegalovirus infection in primitive hematopoietic cell subpopulations","volume":"104","author":"Goodrum","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jcv.2015.12.003_bib0260","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1073\/pnas.95.7.3937","article-title":"Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells","volume":"95","author":"Hahn","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jcv.2015.12.003_bib0265","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.bbmt.2005.05.013","article-title":"Increased levels of tumor necrosis factor alpha are associated with an increased risk of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Reddy","year":"2005","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.jcv.2015.12.003_bib0270","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.bmt.1705891","article-title":"Early lymphocyte recovery post-allogeneic hematopoietic stemcell transplantation is associated with significant graft-versus-leukemia effectwithout increase in graft-versus-host disease in pediatric acute lymphoblastic leukemia","volume":"41","author":"Ishaqi","year":"2008","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.jcv.2015.12.003_bib0275","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbmt.2007.08.051","article-title":"Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma","volume":"14","author":"Hiwase","year":"2008","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.jcv.2015.12.003_bib0280","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.bbmt.2007.07.005","article-title":"Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation","volume":"13","author":"Savani","year":"2007","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.jcv.2015.12.003_bib0285","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1038\/sj.leu.2403055","article-title":"Lymphocyte recovery after allogeneic bone marrow transplantation predicts risk of relapse in acute lymphoblastic leukemia","volume":"17","author":"Kumar","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.jcv.2015.12.003_bib0290","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/sj.bmt.1703262","article-title":"Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia","volume":"28","author":"Kumar","year":"2001","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.jcv.2015.12.003_bib0295","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1046\/j.1365-2141.2003.04294.x","article-title":"Influence of antithymocyte globulin dose on outcome in cytomegalovirus-seropositive recipients of partially T cell-depleted stem cell grafts from matched-unrelated donors","volume":"121","author":"Meijer","year":"2003","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jcv.2015.12.003_bib0300","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/bmt.2013.191","article-title":"Influence of two different doses of antithymocyte globulin in patients with standard-risk disease following haploidentical transplantation: a randomized trial","volume":"49","author":"Wang","year":"2014","journal-title":"Bone Marrow Transpl."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653215007957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653215007957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T22:22:04Z","timestamp":1599949324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653215007957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":60,"alternative-id":["S1386653215007957"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2015.12.003","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for cytomegalovirus DNAemia following haploidentical stem cell transplantation and its association with host hepatitis B virus serostatus","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2015.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}